New Frontiers in Gene Editing
Gene editing is rapidly progressing from being a research/ screening tool to one that promises important applications downstream in drug development, cell therapy and bioprocessing. • Genome editing (e.g., CRISPRs technology to replace defective DNA with “good” DNA) is now a new trend in 2016. The engineered editing system makes use of an enzyme that nicks together DNA with a piece of small RNA that guides the tool to where researchers want to introduce cuts or other changes in the genome.
- Nucleic Acid based Editing: RNA Editing
- RNAi Engineering
- Editing of m-RNA
- Cas-9 application in RNA Modification
- Single Cell Cancer Genomics
- Genetics and genomics of cancer immunity and immunotherapy
- Intra-tumoural and inter-tumour heterogeneity
- ctDNA
Related Conference of New Frontiers in Gene Editing
November 16-17, 2026
19th International Conference on Human Genomics and Genomic Medicine
Tokyo, Japan
February 18-19, 2027
22nd World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
Singapore City, Singapore
March 11-12, 2027
17th International Conference on Human Genetics and Genetic Diseases
Berlin, Germany
Heidelberg Germany
1st EMBL Conference Cancer Genomics Heidelberg Germany
1st to 4th November 2015
San Francisco CA United States of America
Genomic Sample Prep and Biomarker Assay Development DNA RNA Extraction NGS Assays Liquid Biopsy Antibody Validation More San Francisco United States of America
7th to 9th March 2016
San Francisco CA United States of America
Clinical NGS Diagnostics Translating Genomic Data to the Standard of Care San Francisco United States of America
7th to 9th March 2016
San Francisco CA United States of America
Genomics Sequencing Data Integration Analysis and Visualization San Francisco United States of America
10th to 11th March 2016
San Francisco CA United States of America
New Fronteirs in Gene Editing San Francisco United States of America
10th to 11th March 2016
London United Kingdom
HPLC Congress 2016 London United Kingdom
24th to 25th March 2016
Vienna Austria
2016 Genetics and Genomics Conference Vienna Austria
1st to 3rd June 2016
San Diego California United States of America
Genome Editing and Engineering Conference San Diego United States of America
18th to 19th February 2016
Breckenridge Colorado United States of America
Keystone Symposia Stem Cells and Cancer Breckenridge United States of America
6th to 10th March 2016
San Francisco CA United States of America
Clinical NGS Diagnostics Translating Genomic Data to the Standard of Care San Francisco United States of America
7th to 9th March 2016
Singapore
Human Genomics Singapore Singapore
8th to 10th November 2015
Kuala Lumpur Malaysia
The Probiotics Congress Asia Kuala Lumpur Malaysia
29th February to 1st March 2016
Heidelberg Germany
1st EMBL Conference Cancer Genomics Heidelberg Germany
1st to 4th November 2015
San Francisco CA United States of America
Genomic Sample Prep and Biomarker Assay Development DNA RNA Extraction NGS Assays Liquid Biopsy Antibody Validation More San Francisco United States of America
7th to 9th March 2016
San Francisco CA United States of America
Clinical NGS Diagnostics Translating Genomic Data to the Standard of Care San Francisco United States of America
7th to 9th March 2016
San Francisco CA United States of America
Genomics Sequencing Data Integration Analysis and Visualization San Francisco United States of America
10th to 11th March 2016
San Francisco CA United States of America
New Fronteirs in Gene Editing San Francisco United States of America
10th to 11th March 2016
London United Kingdom
HPLC Congress 2016 London United Kingdom
24th to 25th March 2016
Vienna Austria
2016 Genetics and Genomics Conference Vienna Austria
1st to 3rd June 2016
San Diego California United States of America
Genome Editing and Engineering Conference San Diego United States of America
18th to 19th February 2016
Breckenridge Colorado United States of America
Keystone Symposia Stem Cells and Cancer Breckenridge United States of America
6th to 10th March 2016
San Francisco CA United States of America
Clinical NGS Diagnostics Translating Genomic Data to the Standard of Care San Francisco United States of America
7th to 9th March 2016
Singapore
Human Genomics Singapore Singapore
8th to 10th November 2015
Kuala Lumpur Malaysia
The Probiotics Congress Asia Kuala Lumpur Malaysia
29th February to 1st March 2016
New Frontiers in Gene Editing Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2026 (UAE)
- Advanced Imaging and Single-Cell Technologies - cellscience-cs-2027 (UK)
- Animal Genetics - Genome 2027 (Germany)
- Artificial Intelligence in Cell and Molecular Research - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - Genome 2027 (Germany)
- Biomarkers and Microarrays - Genome 2027 (Germany)
- Biotechnology and Molecular Therapeutics - cellscience-cs-2027 (UK)
- Cancer and stem cells - CRISPR 2026 (UAE)
- Cancer Cell Biology and Molecular Oncology - cellscience-cs-2027 (UK)
- Cancer Genomics - Genome 2027 (Germany)
- Cell Biology and Cellular Mechanisms - cellscience-cs-2027 (UK)
- Cellular Metabolism and Metabolic Biology - cellscience-cs-2027 (UK)
- Cellular signaling and Signal Transduction - cellscience-cs-2027 (UK)
- Clinical genomics - Genome 2027 (Germany)
- Comparative Genomics - Genome 2027 (Germany)
- CRISPR technologies and society - CRISPR 2026 (UAE)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2026 (UAE)
- Emerging Technologies and Future Directions in Cell Science - cellscience-cs-2027 (UK)
- Epigenomics and Epigenetics - Genome 2027 (Germany)
- Functional Genomics - Genome 2027 (Germany)
- Gene Editing and Genetic Engineering - Genome 2027 (Germany)
- Genetic Disorder - Genome 2027 (Germany)
- Genetics, Genomics and Genome Biology - cellscience-cs-2027 (UK)
- Genome editing and gene regulation in human health - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2026 (UAE)
- Genome Editing Methods and Novel Tools - CRISPR 2026 (UAE)
- Genomic Instability - Genome 2027 (Germany)
- Genomic Medicine - Genome 2027 (Germany)
- Horizons of CRISPR biology - CRISPR 2026 (UAE)
- Immunology and Cellular Immunity - cellscience-cs-2027 (UK)
- Microbial Genomics - Genome 2027 (Germany)
- Molecular Biology and Gene Regulation - cellscience-cs-2027 (UK)
- Molecular Diagnostics and Biomarkers - cellscience-cs-2027 (UK)
- Molecular Medicine and Translational Research - cellscience-cs-2027 (UK)
- Molecular Microbiology and Host–Pathogen Interactions - cellscience-cs-2027 (UK)
- Next generation sequencing - Genome 2027 (Germany)
- Nutrigenomics - Genome 2027 (Germany)
- Personalized and Regenerative Medicine - Genome 2027 (Germany)
- Pharmacogenomics - Genome 2027 (Germany)
- Plant and Animal Biotechnology - CRISPR 2026 (UAE)
- Plant Genomics and Molecular Pharming - Genome 2027 (Germany)
- Stem Cell Biology and Regenerative Medicine - cellscience-cs-2027 (UK)
- Structural Biology and Bioinformatics - CRISPR 2026 (UAE)
- Structural Genomics - Genome 2027 (Germany)
- Therapeutic Genome Editing - CRISPR 2026 (UAE)
- Trends in Genomics and Pharmacogenomics - Genome 2027 (Germany)